TP53 and plasma cell myeloma: Chang et al. reported hemizygous TP53 deletion in 8 out of 9 MM cases with CNS involvement, suggesting that an exceptionally high incidence of TP53 deletions in these patients might account for metastatic features of myeloma cells [506].